Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 56 referenced papers

Top Authors

Wendy K. Chung
Boston Children's Hospital
Sébastien Jacquemont
Centre Hospitalier Universitaire Sainte-Justine
Alexandre Reymond
University of Lausanne
Mieke M. van Haelst
Amsterdam University Medical Centers
Raphael Bernier
University of Washington
Carrie E. Bearden
University of California, Los Angeles
Evan E. Eichler
Howard Hughes Medical Institute
Jacob A. S. Vorstman
University of Toronto
Anne Manuela Maillard
Centre Hospitalier Universitaire Vaudois

Top Institutions

Ranked by publications Top 10 institutions

References

References (56)
  1. 1

    Developmental presentation, medical complexities, and service delivery for a child with 16p11.2 deletion syndrome.

    Bamonte L

    Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association 2015; (27(1)):90-9 doi:10.1097/PEP.0000000000000105.

    PMID: 25521272
  2. 2

    TBX6 null variants and a common hypomorphic allele in congenital scoliosis.

    Wu N, Ming X, Xiao J, et al.

    The New England journal of medicine 2015; (372(4)):341-50 doi:10.1056/NEJMoa1406829.

    PMID: 25564734
  3. 3

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Richards S, Aziz N, Bale S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

    PMID: 25741868
  4. 4

    Genetic and structural variation in the SH2B1 gene in the Belgian population.

    Aerts E, Beckers S, Zegers D, et al.

    Molecular genetics and metabolism 2015; (115(4)):193-8.

    PMID: 26031769
  5. 5

    Maternal Modifiers and Parent-of-Origin Bias of the Autism-Associated 16p11.2 CNV.

    Duyzend MH, Nuttle X, Coe BP, et al.

    American journal of human genetics 2016; (98(1)):45-57.

    PMID: 26749307
  6. 6

    Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes.

    Loviglio MN, Leleu M, Männik K, et al.

    Molecular psychiatry 2017; (22(6)):836-849 doi:10.1038/mp.2016.84.

    PMID: 27240531
  7. 7

    16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort.

    Steinman KJ, Spence SJ, Ramocki MB, et al.

    American journal of medical genetics. Part A 2016; (170(11)):2943-2955 doi:10.1002/ajmg.a.37820.

    PMID: 27410714
  8. 8

    Developmental trajectories for young children with 16p11.2 copy number variation.

    Bernier R, Hudac CM, Chen Q, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2017; (174(4)):367-380 doi:10.1002/ajmg.b.32525.

    PMID: 28349640
  9. 9

    Discordant phenotypes in monozygotic twins with 16p11.2 microdeletions including the SH2B1 gene.

    Li L, Huang L, Lin S, et al.

    American journal of medical genetics. Part A 2017; (173(8)):2284-2288 doi:10.1002/ajmg.a.38284.

    PMID: 28544142
  10. 10

    The Immune Signaling Adaptor LAT Contributes to the Neuroanatomical Phenotype of 16p11.2 BP2-BP3 CNVs.

    Loviglio MN, Arbogast T, Jønch AE, et al.

    American journal of human genetics 2017; (101(4)):564-577 doi:10.1016/j.ajhg.2017.08.016.

    PMID: 28965845
  11. 11

    Diversity in peptide recognition by the SH2 domain of SH2B1.

    McKercher MA, Guan X, Tan Z, Wuttke DS

    Proteins 2018; (86(2)):164-176 doi:10.1002/prot.25420.

    PMID: 29127727
  12. 12

    Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion.

    Mei C, Fedorenko E, Amor DJ, et al.

    European journal of human genetics : EJHG 2018; (26(5)):676-686 doi:10.1038/s41431-018-0102-x.

    PMID: 29445122
  13. 13

    The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus.

    Giuranna J, Volckmar AL, Heinen A, et al.

    Obesity facts 2018; (11(2)):93-108 doi:10.1159/000486962.

    PMID: 29631267
  14. 14

    An Update on Common Chromosome Microdeletion and Microduplication Syndromes.

    Goldenberg P

    Pediatric annals 2018; (47(5)):e198-e203 doi:10.3928/19382359-20180419-01.

    PMID: 29750287
  15. 15

    PRRT2-related phenotypes in patients with a 16p11.2 deletion.

    Vlaskamp DRM, Callenbach PMC, Rump P, et al.

    European journal of medical genetics 2019; (62(4)):265-269 doi:10.1016/j.ejmg.2018.08.002.

    PMID: 30125676
  16. 16

    Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.

    Pizzo L, Jensen M, Polyak A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(4)):816-825 doi:10.1038/s41436-018-0266-3.

    PMID: 30190612
  17. 17

    Quantitative gait assessment in children with 16p11.2 syndrome.

    Goldman S, McCullough AK, Young SD, et al.

    Journal of neurodevelopmental disorders 2019; (11(1)):26 doi:10.1186/s11689-019-9286-9.

    PMID: 31656164
  18. 18

    Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease.

    Jiang L, Su H, Wu X, et al.

    Nature communications 2020; (11(1)):1517 doi:10.1038/s41467-020-15328-3.

    PMID: 32251290
  19. 19

    Ocular Findings in the 16p11.2 Microdeletion Syndrome: A Case Report and Literature Review.

    Stingl CS, Jackson-Cook C, Couser NL

    Case reports in pediatrics 2020; (2020()):2031701 doi:10.1155/2020/2031701.

    PMID: 32373379
  20. 20

    Who ever heard of 16p11.2 deletion syndrome? Parents' perspectives on a susceptibility copy number variation syndrome.

    Kleinendorst L, van den Heuvel LM, Henneman L, van Haelst MM

    European journal of human genetics : EJHG 2020; (28(9)):1196-1204 doi:10.1038/s41431-020-0644-6.

    PMID: 32415274
  21. 21

    Phenotypes Associated with 16p11.2 Copy Number Gains and Losses at a Single Institution.

    Chu C, Wu H, Xu F, et al.

    Laboratory medicine 2020; (51(6)):642-648 doi:10.1093/labmed/lmaa026.

    PMID: 32537635
  22. 22

    Evaluating heterogeneity in ASD symptomatology, cognitive ability, and adaptive functioning among 16p11.2 CNV carriers.

    Hudac CM, Bove J, Barber S, et al.

    Autism research : official journal of the International Society for Autism Research 2020; (13(8)):1300-1310 doi:10.1002/aur.2332.

    PMID: 32597026
  23. 23

    A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants.

    Chawner SJRA, Doherty JL, Anney RJL, et al.

    The American journal of psychiatry 2021; (178(1)):77-86 doi:10.1176/appi.ajp.2020.20010015.

    PMID: 33384013
  24. 24

    Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs.

    Sønderby IE, Ching CRK, Thomopoulos SI, et al.

    Human brain mapping 2022; (43(1)):300-328 doi:10.1002/hbm.25354.

    PMID: 33615640
  25. 25

    16p11.2 deletion syndrome.

    Chung WK, Roberts TP, Sherr EH, et al.

    Current opinion in genetics & development 2021; (68()):49-56 doi:10.1016/j.gde.2021.01.011.

    PMID: 33667823
  26. 26

    Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: A case series.

    Welling MS, de Groot CJ, Kleinendorst L, et al.

    Clinical obesity 2021; (11(6)):e12481 doi:10.1111/cob.12481.

    PMID: 34291582
  27. 27

    Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion.

    Giannopoulou EZ, Zorn S, Schirmer M, et al.

    Hormone research in paediatrics 2022; (95(2)):137-148 doi:10.1159/000520402.

    PMID: 34689140
  28. 28

    Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates.

    Zouk H, Yu W, Oza A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(2)):454-462 doi:10.1016/j.gim.2021.10.010.

    PMID: 34906510
  29. 29

    Generation of a human iPSC line CIPi001-A from a benign familial infantile epilepsy patient related 16p11.2 deletion.

    Ji X, Gao Y, Zhang P, et al.

    Stem cell research 2022; (59()):102634 doi:10.1016/j.scr.2021.102634.

    PMID: 34995844
  30. 30

    Molecular cytogenetic characterization of 16p11.2 microdeletions with diverse prenatal phenotypes: Four cases report and literature review.

    Yue F, Xi Q, Zhang X, et al.

    Taiwanese journal of obstetrics & gynecology 2022; (61(3)):544-550 doi:10.1016/j.tjog.2022.03.027.

    PMID: 35595456
  31. 31

    [Clinical phenotype and genetic features of 16p11.2 microdeletion-related epilepsy in children].

    Lai CY, Chen RH, Zhong CL, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2022; (24(5)):585-590 doi:10.7499/j.issn.1008-8830.2111110.

    PMID: 35644201
  32. 32

    Measuring hyperphagia in patients with monogenic and syndromic obesity.

    Zorn S, von Schnurbein J, Schirmer M, et al.

    Appetite 2022; (178()):106161 doi:10.1016/j.appet.2022.106161.

    PMID: 35809703
  33. 33

    Sensory processing in 16p11.2 deletion and 16p11.2 duplication.

    Smith H, Lane C, Al-Jawahiri R, Freeth M

    Autism research : official journal of the International Society for Autism Research 2022; (15(11)):2081-2098 doi:10.1002/aur.2802.

    PMID: 36053814
  34. 34

    Statistical and functional convergence of common and rare genetic influences on autism at chromosome 16p.

    Weiner DJ, Ling E, Erdin S, et al.

    Nature genetics 2022; (54(11)):1630-1639 doi:10.1038/s41588-022-01203-y.

    PMID: 36280734
  35. 35

    SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort.

    da Fonseca ACP, Assis ISS, Salum KCR, et al.

    Eating and weight disorders : EWD 2022; (27(8)):3665-3674 doi:10.1007/s40519-022-01506-3.

    PMID: 36436143
  36. 36

    How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey.

    Mighton C, Clausen M, Shickh S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(5)):100819 doi:10.1016/j.gim.2023.100819.

    PMID: 36919843
  37. 37

    The Phenotypic variability of 16p11.2 distal BP2-BP3 deletion in a transgenerational family and in neurodevelopmentally ascertained samples.

    Woodbury-Smith M, D'Abate L, Stavropoulos DJ, et al.

    Journal of medical genetics 2023; (60(12)):1153-1160 doi:10.1136/jmg-2022-108818.

    PMID: 37290907
  38. 38

    Chromosomal deletions on 16p11.2 encompassing SH2B1 are associated with accelerated metabolic disease.

    Hanssen R, Auwerx C, Jõeloo M, et al.

    Cell reports. Medicine 2023; (4(8)):101155 doi:10.1016/j.xcrm.2023.101155.

    PMID: 37586323
  39. 39

    Health supervision for children and adolescents with 16p11.2 deletion syndrome.

    Chung WK, Herrera FF,

    Cold Spring Harbor molecular case studies 2023; (9(4)) doi:10.1101/mcs.a006316.

    PMID: 38050025
  40. 40

    Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options.

    Vos N, Kleinendorst L, van der Laan L, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1387-1401 doi:10.1038/s41431-024-01601-2.

    PMID: 38605127
  41. 41

    Variant classification changes over time in the clinical molecular diagnostic laboratory setting.

    Hahn E, Mighton C, Fisher Y, et al.

    Journal of medical genetics 2024; (61(8)):788-793 doi:10.1136/jmg-2023-109772.

    PMID: 38806232
  42. 42

    SH2B1 Defends Against Energy Imbalance, Obesity, and Metabolic Disease via a Paraventricular Hypothalamus→Dorsal Raphe Nucleus Neurocircuit.

    Li Y, Kim MH, Jiang L, et al.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; (11(31)):e2400437 doi:10.1002/advs.202400437.

    PMID: 38885417
  43. 43

    Prenatal phenotypes and pregnancy outcomes of fetuses with 16p11.2 microdeletion/microduplication.

    Yue F, Hao M, Jiang D, et al.

    BMC pregnancy and childbirth 2024; (24(1)):494 doi:10.1186/s12884-024-06702-w.

    PMID: 39039444
  44. 44

    The Phenotypic Spectrum of 16p11.2 Recurrent Chromosomal Rearrangements.

    Mitrakos AK, Kosma K, Makrythanasis P, Tzetis M

    Genes 2024; (15(8)) doi:10.3390/genes15081053.

    PMID: 39202413
  45. 45

    Chromosome 16p11.2 microdeletion syndrome with microcephaly and Dandy-Walker malformation spectrum: expanding the known phenotype.

    Elsayed LEO, AlHarbi NA, Alqarni AM, et al.

    Human genomics 2024; (18(1)):95 doi:10.1186/s40246-024-00662-0.

    PMID: 39232803
  46. 46

    Endogenous SH2B1 protein localizes to lamellipodia and filopodia: platinum replica electron-microscopy study.

    Diakonova M, Carter-Su C, Svitkina T

    microPublication biology 2025; (2025()) doi:10.17912/micropub.biology.001451.

    PMID: 39897164
  47. 47

    Genomic deletions on 16p11.2 associated with severe obesity in Brazil.

    da Silva Assis IS, Salum KCR, Felício RFM, et al.

    Frontiers in endocrinology 2024; (15()):1495534 doi:10.3389/fendo.2024.1495534.

    PMID: 39897959
  48. 48

    PRRT 2-Related Epilepsy: From Self-Limited Infantile Epilepsy to Atypical Epilepsy Phenotypes.

    Komar M, Sidhu J, Joseph J, et al.

    Neurology. Genetics 2025; (11(3)):e200267 doi:10.1212/NXG.0000000000200267.

    PMID: 40401013
  49. 49

    MaveMD: A functional data resource for genomic medicine.

    McEwen AE, Stone J, Tejura M, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.11.15.25336228.

    PMID: 41332838
  50. 50

    Reclassification of variants of uncertain significance in type I collagen genes: a national reference laboratory experience.

    Supari N, Baker D, Keigwin S, et al.

    Journal of medical genetics 2026; (63(5)):277-283 doi:10.1136/jmg-2025-111334.

    PMID: 41667232
  51. 51

    Combinatorial effects of gene dosage, polygenic background and environment on complex traits.

    Sacks MF, Klein M, Bigdeli TB, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.04.30.26352063.

    PMID: 42094142
  52. 52

    [Prenatal ultrasound and genetic characteristics of 60 fetuses with 16p11.2 microdeletion].

    Pan L, Wu J, Duan S, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2026; (51(4)):737-743 doi:10.11817/j.issn.1672-7347.2026.260007.

    PMID: 42394496
  53. 53

    Coexistence of a Novel OCRL Variant and a Pathogenic 16p11.2 Deletion in a Patient with Renal and Neurodevelopmental Manifestations Suggestive of Atypical Dent Disease Type 2-A Case Report.

    Chronis C, Stefanaki C, Stergiou N, et al.

    Journal of clinical medicine 2026; (15(14)) doi:10.3390/jcm15145613.

    PMID: 42513527
  54. 54

    Contrasting outcomes of 16p11.2 microdeletion and microduplication in prenatal diagnosis: phenotypic variability and genetic counseling strategies.

    Guo Q, Zhang L, Zuo Y, et al.

    Psychiatric genetics 2026; (36(3)):151-155 doi:10.1097/YPG.0000000000000421.

    PMID: 42583927
  55. 55

    The Importance of Familial Co-segregation in the Classification of a Novel PKD1 Variant Associated With Autosomal Dominant Polycystic Kidney Disease.

    Vasconcelos AP, Rocha L, Fernandes S, Oliveira JP

    American journal of medical genetics. Part A 2026; doi:10.1002/ajmg.a.70298.

    PMID: 42702893
  56. 56

    Metabolic dysfunction-associated steatotic liver disease assessment and management: Clinical practice guidance from the Canadian Association for the Study of the Liver.

    Kehar M, Ramji A, Swain M, et al.

    Canadian liver journal 2026; (9(3)):345-388 doi:10.3138/canlivj-2026-9-3-guidelines.

    PMID: 42872191